{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:42:35Z","timestamp":1791024155799,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T00:00:00Z","timestamp":1316131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024895","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T16:58:24Z","timestamp":1316192304000},"page":"e24895","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study"],"prefix":"10.1371","volume":"6","author":[{"given":"Hongmei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/biof.12","article-title":"Endocrine fibroblast growth factors as regulators of metabolic homeostasis.","volume":"35","author":"H Kurosu","year":"2009","journal-title":"BioFactors"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.","volume":"342","author":"N Itoh","year":"2010","journal-title":"Cell and Tissue Research"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.coph.2009.07.001","article-title":"FGFs and metabolism.","volume":"9","author":"A Kharitonenkov","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.","volume":"27","author":"R Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.","volume":"5","author":"MK Badman","year":"2007","journal-title":"Cell Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21.","volume":"104","author":"Y Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver.","volume":"1492","author":"T Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","article-title":"Fibroblast growth factor-21 improves pancreatic b-cell function and survival by activation of extracellular signal regulated kinase 1\/2 and Akt signaling pathways.","volume":"55","author":"W Wente","year":"2006","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/MCB.00992-07","article-title":"Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblst growth factor 21 that are selectively repressed by SIRT1 in adipocytes.","volume":"28","author":"H Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine.","volume":"582","author":"Y Izumiya","year":"2008","journal-title":"FEBS Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4773(00)00439-1","article-title":"Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.","volume":"98","author":"S Ito","year":"2000","journal-title":"Mech Dev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.","volume":"5","author":"T Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator.","volume":"115","author":"A Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.","volume":"148","author":"A Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice.","volume":"58","author":"J Xu","year":"2009","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-985148","article-title":"Circulating FGF-21 levels in normal subjects and in newly diagnosed patients with type 2 diabetes mellitus.","volume":"116","author":"WW Chen","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.","volume":"57","author":"X Zhang","year":"2008","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2337\/db08-1775","article-title":"Free fatty acids link metabolism and regulation of the insulin-sensitizing Fibroblast Growth Factor-21.","volume":"58","author":"K Mai","year":"2009","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/jc.2008-2331","article-title":"Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.","volume":"94","author":"H Li","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.","volume":"53","author":"H Li","year":"2010","journal-title":"Journal of Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.","volume":"139","author":"J Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.","volume":"40","author":"Yilmaz Yusuf","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.07.003","article-title":"Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice.","volume":"53","author":"G Morris-Stiff","year":"2010","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.","volume":"288","author":"LS Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1373\/clinchem.2010.155184","article-title":"Circadian Rhythm of Circulating Fibroblast Growth Factor 21 (FGF21) Is Related to the Diurnal Changes in Fatty Acids in Humans.","volume":"57","author":"H Yu","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/dia.2010.0101","article-title":"Increased Liver fat content and Unfavorable Glucose Profiles in Subjects Without Diabetes.","volume":"13","author":"H Bian","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-10-0454","article-title":"Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serumfibroblast growth factor 21 levels.","volume":"163","author":"D Cuevas-Ramos","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPAR alpha-mediated induction of fibroblast growth factor 21.","volume":"5","author":"T Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes: a possible link to improved insulin sensitivity.","volume":"582","author":"P Arner","year":"2008","journal-title":"FEBS Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.","volume":"106","author":"MJ Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmri.1880050311","article-title":"Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.","volume":"5","author":"R Longo","year":"1995","journal-title":"J Magn Reson Imaging"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.","volume":"355","author":"R Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.","volume":"54","author":"KF Petersen","year":"2005","journal-title":"Diabetes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T15:58:56Z","timestamp":1560614336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024895"}},"subtitle":[],"editor":[{"given":"Aimin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,16]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024895","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,16]]}}}